Craig L. Weinstock, the Sr. VP. & Gen. Counsel of $NOV, sold 10,495 shares of the company on 02-23-2026 for an estimated $209,270. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.8% of their shares of this class of stock. Following this trade, they now own 265,824 shares of this class of $NOV stock.
$NOV Insider Trading Activity
$NOV insiders have traded $NOV stock on the open market 7 times in the past 6 months. Of those trades, 2 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $NOV stock by insiders over the last 6 months:
- JOSEPH W ROVIG (President - Energy Equipment) sold 151,086 shares for an estimated $3,046,694
- CRAIG L. WEINSTOCK (Sr. VP. & Gen. Counsel) has made 0 purchases and 4 sales selling 70,000 shares for an estimated $1,405,421.
- CHRISTIAN S KENDALL has made 2 purchases buying 70,000 shares for an estimated $1,012,200 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NOV Hedge Fund Activity
We have seen 196 institutional investors add shares of $NOV stock to their portfolio, and 281 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC removed 7,280,774 shares (-18.3%) from their portfolio in Q4 2025, for an estimated $113,798,497
- PRICE T ROWE ASSOCIATES INC /MD/ added 4,785,015 shares (+1743.9%) to their portfolio in Q4 2025, for an estimated $74,789,784
- PACER ADVISORS, INC. removed 3,267,354 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $51,068,743
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 2,970,048 shares (-76.2%) from their portfolio in Q4 2025, for an estimated $46,421,850
- ROYAL BANK OF CANADA removed 2,473,483 shares (-98.0%) from their portfolio in Q4 2025, for an estimated $38,660,539
- BANK OF AMERICA CORP /DE/ removed 1,435,821 shares (-26.9%) from their portfolio in Q4 2025, for an estimated $22,441,882
- UBS GROUP AG removed 1,311,204 shares (-68.2%) from their portfolio in Q4 2025, for an estimated $20,494,118
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NOV Revenue
$NOV had revenues of $2.3B in Q4 2025. This is a decrease of -1.34% from the same period in the prior year.
You can track NOV financials on Quiver Quantitative's NOV stock page.
$NOV Analyst Ratings
Wall Street analysts have issued reports on $NOV in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Underweight" rating on 10/30/2025
- Stifel issued a "Buy" rating on 10/29/2025
- RBC Capital issued a "Outperform" rating on 10/29/2025
To track analyst ratings and price targets for $NOV, check out Quiver Quantitative's $NOV forecast page.
$NOV Price Targets
Multiple analysts have issued price targets for $NOV recently. We have seen 9 analysts offer price targets for $NOV in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- Scott Gruber from Citigroup set a target price of $20.0 on 02/11/2026
- Phillip Jungwirth from BMO Capital set a target price of $20.0 on 02/09/2026
- Luke Lemoine from Piper Sandler set a target price of $18.0 on 02/09/2026
- Stephen Gengaro from Stifel set a target price of $21.0 on 02/06/2026
- David Anderson from Barclays set a target price of $20.0 on 02/04/2026
- Marc Bianchi from TD Cowen set a target price of $22.0 on 01/07/2026
- Charles Minervino from Susquehanna set a target price of $20.0 on 01/07/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
